Cargando…
Is Vedolizumab Truly Gut Selective? It May Not Affect the Immunogenicity of Vaccines in Patients With Inflammatory Bowel Disease
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802035/ https://www.ncbi.nlm.nih.gov/pubmed/36777763 http://dx.doi.org/10.1093/crocol/otaa086 |
_version_ | 1784861608318599168 |
---|---|
author | Lee, Alexander S Caldera, Freddy |
author_facet | Lee, Alexander S Caldera, Freddy |
author_sort | Lee, Alexander S |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9802035 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-98020352023-02-10 Is Vedolizumab Truly Gut Selective? It May Not Affect the Immunogenicity of Vaccines in Patients With Inflammatory Bowel Disease Lee, Alexander S Caldera, Freddy Crohns Colitis 360 Editorials Oxford University Press 2020-10-27 /pmc/articles/PMC9802035/ /pubmed/36777763 http://dx.doi.org/10.1093/crocol/otaa086 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of Crohn's & Colitis Foundation. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Editorials Lee, Alexander S Caldera, Freddy Is Vedolizumab Truly Gut Selective? It May Not Affect the Immunogenicity of Vaccines in Patients With Inflammatory Bowel Disease |
title | Is Vedolizumab Truly Gut Selective? It May Not Affect the Immunogenicity of Vaccines in Patients With Inflammatory Bowel Disease |
title_full | Is Vedolizumab Truly Gut Selective? It May Not Affect the Immunogenicity of Vaccines in Patients With Inflammatory Bowel Disease |
title_fullStr | Is Vedolizumab Truly Gut Selective? It May Not Affect the Immunogenicity of Vaccines in Patients With Inflammatory Bowel Disease |
title_full_unstemmed | Is Vedolizumab Truly Gut Selective? It May Not Affect the Immunogenicity of Vaccines in Patients With Inflammatory Bowel Disease |
title_short | Is Vedolizumab Truly Gut Selective? It May Not Affect the Immunogenicity of Vaccines in Patients With Inflammatory Bowel Disease |
title_sort | is vedolizumab truly gut selective? it may not affect the immunogenicity of vaccines in patients with inflammatory bowel disease |
topic | Editorials |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802035/ https://www.ncbi.nlm.nih.gov/pubmed/36777763 http://dx.doi.org/10.1093/crocol/otaa086 |
work_keys_str_mv | AT leealexanders isvedolizumabtrulygutselectiveitmaynotaffecttheimmunogenicityofvaccinesinpatientswithinflammatoryboweldisease AT calderafreddy isvedolizumabtrulygutselectiveitmaynotaffecttheimmunogenicityofvaccinesinpatientswithinflammatoryboweldisease |